Mettler-Toledo International (NYSE:MTD) Rating Lowered to Hold at Wall Street Zen

Mettler-Toledo International (NYSE:MTD) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Saturday.

MTD has been the subject of several other research reports. Evercore ISI increased their price objective on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a report on Tuesday, October 7th. Morgan Stanley started coverage on shares of Mettler-Toledo International in a report on Tuesday, December 2nd. They issued an “equal weight” rating and a $1,550.00 target price on the stock. Citigroup lifted their price target on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a report on Monday, November 10th. JPMorgan Chase & Co. upped their price objective on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research note on Thursday, October 9th. Finally, Stifel Nicolaus boosted their target price on Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a report on Monday, November 10th. Six research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $1,441.67.

Mettler-Toledo International Price Performance

Shares of NYSE:MTD opened at $1,370.92 on Friday. The company’s 50-day moving average price is $1,432.30 and its two-hundred day moving average price is $1,354.39. Mettler-Toledo International has a one year low of $946.69 and a one year high of $1,525.17. The stock has a market capitalization of $28.01 billion, a PE ratio of 34.19, a price-to-earnings-growth ratio of 4.08 and a beta of 1.42.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, beating the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a negative return on equity of 426.96% and a net margin of 21.20%.The company had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $997.36 million. During the same quarter last year, the company earned $10.21 EPS. Mettler-Toledo International’s revenue for the quarter was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. On average, analysts anticipate that Mettler-Toledo International will post 42.71 earnings per share for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In related news, Director Elisha W. Finney sold 474 shares of the firm’s stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $1,433.57, for a total transaction of $679,512.18. Following the transaction, the director directly owned 311 shares of the company’s stock, valued at approximately $445,840.27. This trade represents a 60.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Gerry Keller sold 236 shares of Mettler-Toledo International stock in a transaction dated Friday, November 21st. The stock was sold at an average price of $1,418.58, for a total transaction of $334,784.88. Following the completion of the sale, the insider owned 159 shares of the company’s stock, valued at $225,554.22. This trade represents a 59.75% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 19,565 shares of company stock worth $28,683,737. 0.77% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Mettler-Toledo International

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Corient Private Wealth LLC raised its position in Mettler-Toledo International by 91.8% in the second quarter. Corient Private Wealth LLC now owns 140,267 shares of the medical instruments supplier’s stock valued at $164,775,000 after purchasing an additional 67,149 shares during the last quarter. Principal Financial Group Inc. increased its stake in shares of Mettler-Toledo International by 2.9% in the third quarter. Principal Financial Group Inc. now owns 298,429 shares of the medical instruments supplier’s stock valued at $366,354,000 after buying an additional 8,360 shares during the period. Stance Capital LLC acquired a new position in shares of Mettler-Toledo International in the second quarter valued at approximately $2,012,000. Claret Asset Management Corp bought a new position in Mettler-Toledo International in the 2nd quarter valued at approximately $235,000. Finally, Nordea Investment Management AB boosted its position in Mettler-Toledo International by 10.2% during the 3rd quarter. Nordea Investment Management AB now owns 140,680 shares of the medical instruments supplier’s stock worth $167,419,000 after buying an additional 13,056 shares during the period. 95.07% of the stock is currently owned by institutional investors and hedge funds.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.